TS-070103 — The Need Aerobiology chambers on the market today face several challenges, particularly in studying biohazardous aerosols and testing anti-bioaerosol agents. Large, room-sized chambers, while capable of mimicking indoor environments, are cumbersome to operate, require extensive decontamination, an…

TS-038312 — A novel, intravitreal microparticle injection capable of controlled-release of protein therapies (including anti-VEGF) for tunable periods of 6-12 months after injection for the treatment of age-related macular degeneration.